IBDEI0KQ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9327,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,9327,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,9327,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,9328,0)
 ;;=D81.810^^39^411^5
 ;;^UTILITY(U,$J,358.3,9328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9328,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,9328,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,9328,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,9329,0)
 ;;=E88.01^^39^411^2
 ;;^UTILITY(U,$J,358.3,9329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9329,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,9329,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,9329,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,9330,0)
 ;;=J09.X1^^39^411^25
 ;;^UTILITY(U,$J,358.3,9330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9330,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,9330,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,9330,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,9331,0)
 ;;=J09.X2^^39^411^26
 ;;^UTILITY(U,$J,358.3,9331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9331,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,9331,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,9331,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,9332,0)
 ;;=J09.X3^^39^411^27
 ;;^UTILITY(U,$J,358.3,9332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9332,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,9332,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,9332,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,9333,0)
 ;;=J09.X9^^39^411^28
 ;;^UTILITY(U,$J,358.3,9333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9333,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,9333,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,9333,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,9334,0)
 ;;=J44.9^^39^411^14
 ;;^UTILITY(U,$J,358.3,9334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9334,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,9334,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,9334,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,9335,0)
 ;;=J44.1^^39^411^13
 ;;^UTILITY(U,$J,358.3,9335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9335,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,9335,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,9335,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,9336,0)
 ;;=J42.^^39^411^10
 ;;^UTILITY(U,$J,358.3,9336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9336,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,9336,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,9336,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,9337,0)
 ;;=J43.9^^39^411^22
 ;;^UTILITY(U,$J,358.3,9337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9337,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,9337,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,9337,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,9338,0)
 ;;=J43.0^^39^411^30
 ;;^UTILITY(U,$J,358.3,9338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9338,1,3,0)
 ;;=3^MacLeod's Syndrome
 ;;^UTILITY(U,$J,358.3,9338,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,9338,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,9339,0)
 ;;=J43.1^^39^411^21
 ;;^UTILITY(U,$J,358.3,9339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9339,1,3,0)
 ;;=3^Emphysema,Panlobular
 ;;^UTILITY(U,$J,358.3,9339,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,9339,2)
 ;;=^5008236
